Hot Sliver Stocks To Buy Right Now

We get it, Apple (NASDAQ: AAPL  ) . You own the domestic smartphone market. comScore just pegged you at a 39.2% market share of U.S. smartphone subscribers. Now, investors need to see some international iPhone wins.

Usually, investors have to wait for domestic carriers to report iPhone activation figures to get a proxy for Apple’s mix. Not all carriers have released earnings results quite yet, and AT&T has even decided to stop providing iPhone figures. Fortunately, all’s not lost.

On the conference call, Apple CFO Peter Oppenheimer disclosed that iPhone unit sales in the U.S. rose an impressive 51% last quarter, well above the total 20% gain that Apple posted in iPhone unit sales. However, Apple doesn’t normally disclose the geographical mix of iPhones to investors, so it’s difficult to interpret that 51% jump.

It has in the past, though, if you just know where to look. As part of its massive legal battle with Samsung last year, Apple did disclose through court filings that it sold 8.3 million iPhones in the U.S. in calendar Q2 last year. That means that Apple just sold 12.6 million iPhones in the U.S. this past quarter.

Hot Sliver Stocks To Buy Right Now: Higher One Holdings Inc.(ONE)

Higher One Holdings, Inc. provides technology and payment services in the United States. It offers a suite of disbursement and payment solutions for higher education institutions and their students. The company provides OneDisburse Refund Management product that offers higher education institutional clients with a technology service for streamlining the student refund disbursement process. It also offers CASHNet Payment suite that includes software-as-a-service products and services, such as ePayment to securely accept online payments for tuition, charges, and fees from students through credit card, pinless debit, and ACH; eBill to automate payer billing and processing functions; MyPaymentPlan to personalize students? payment plans; eMarket that allows academic, athletic, and other departments to take alumni donations, sell event tickets and other merchandise, and accept payments of event and conference registration fees; and Cashiering to operate and manage cashiering fu nctions, back office payments, and campus-wide departmental deposits. In addition, the company provides OneDisburse ID, which offers an option to combine the company?s debit card with the institution?s ID cards; OneDisburse Payroll to distribute payroll and other employee-related payments; OneDisburse PLUS product to distribute Parent PLUS loan refunds to parents on behalf of the school; and Financial Intelligence to students with an online class. Further, it provides student-oriented banking services to campus communities. Additionally, the company offers OneAccount product for students, as well as faculty, staff, and alumni, with an FDIC-insured online checking account and a debit MasterCard ATM card. Higher One Holdings, Inc. was founded in 2000 and is headquartered in New Haven, Connecticut.

Advisors’ Opinion:

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Higher One Holdings (NYSE: ONE  ) , whose recent revenue and earnings are plotted below.

  • [By Roberto Pedone]

    One under-$10 business services player that looks poised for a run higher is Higher One (ONE), which provides technology-based refund disbursement, payment processing and data analytics services to higher education institutions and students. It also provides banking services to campus communities. This stock has been hit hard by the bears so far in 2013, with shares down by 26%.

    If you take a look at the chart for Higher One, you’ll notice that this stock has been downtrending badly for the last three months, with shares plunging from its high of $11.93 to its recent low of $6.97 a share. During that downtrend, shares of ONE were consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of ONE have recently formed a double bottom chart pattern at $7.05 to $6.97 a share. This stock has now started to rebound sharply off that double bottom and move within range of triggering a near-term breakout trade.

    Traders should now look for long-biased trades in ONE if it manages to break out above some near-term overhead resistance at $7.85 a share and then once it clears its 50-day moving average at $8.11 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 196,360 shares. If that breakout triggers soon, then ONE will set up to re-test or possibly take out its next major overhead resistance levels at $9 to its 200-day moving average of $9.77 a share. This stock could even tag $11 a share if that 200-day gets taken out with volume.

    Traders can look to buy ONE off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $7.39 a share, or below $7 a share. One can also buy ONE off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Higher One Holdings (NYSE: ONE  ) , whose recent revenue and earnings are plotted below.

Hot Sliver Stocks To Buy Right Now: Westlake Chemical Corporation(WLK)

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and fabricated building products. It operates in two segments, Olefins and Vinyls. The Olefins segment provides ethylene, polyethylene, styrene monomer, and various ethylene co-products, such as chemical grade propylene, crude butadiene, pyrolysis gasoline, and hydrogen. The Vinyls segment offers polyvinyl chloride (PVC), vinyl chloride monomer, ethylene dichloride, chlorine, caustic soda, and ethylene. This segment also manufactures and sells products fabricated from PVC, including water, sewer, irrigation, and conduit pipes; window and door profiles; and fences. The company?s products are used in various applications, such as consumer and industrial markets comprising flexible and rigid packaging, automotive products, coatings, and residential and commercial construction, as well as in other durable and non-durable goods. Westlake Chemical Corporation provides its products for chem ical processors, plastics fabricators, construction contractors, municipalities, and supply warehouses in the United States, Canada, Singapore, and internationally. The company was founded in 1985 and is headquartered in Houston, Texas.

Advisors’ Opinion:

  • [By Louis Navellier]

    To get to the point, here are five companies that have the analyst community buzzing, and they should be on your radar as well.

    Facebook (FB): In the past three months, estimates have been revised up 23%. Analysts now expect 47.5% annual sales growth and 58.8% earnings growth this quarter. . Melco Crown Entertainment (MPEL): In the past three months, estimates have been upwardly revised 12%. Analysts now expect 19.9% sales growth and 85% earnings growth. MPEL is a strong buy. Netflix (NFLX): In the past three months, estimates have been upwardly revised 41%. Analysts now expect 23.5% sales growth and 400% earnings growth. NFLX is a strong buy. Westlake Chemical (WLK): In the past three months, estimates have been revised up 13%. Analysts now expect 15.6% sales growth and 50% earnings growth this quarter. . Nu Skin Enterprises (NUS): In the past three months, estimates have been revised up 17%. Analysts now expect 78.1% sales growth and 97.9% earnings growth. NUS is a strong buy.

    To put these earnings estimates into perspective, analysts forecast that the average S&P 500 company will grow earnings by 8.8% this quarter. This means that each of the five buys above are well-positioned to win this earnings season.

  • [By Jake L’Ecuyer]

    Westlake Chemical (NYSE: WLK) shot up 2.14 percent to $120.83 after analysts at Susquehanna upgraded the stock from Neutral to Positive and lifted the target price from $118 to $145.

  • [By Johanna Bennett]

    Dow isn’t the only chemical play gaining on the news.  Axiall (AXLL) rose 9.3% to $49.58 in Monday market action. Olin (OLN) rose 6.1% to $26.36. And Westlake Chemical (WLK) rose 2.2% to $115.10.

Hot Sliver Stocks To Buy Right Now: Osaka Gas Co Ltd (OSA)

OSAKA GAS CO., LTD. is primarily engaged in gas business. It operates in four business segments. The Gas segment is involved in the production, supply and sale of gas, the sale of gas equipment and housing equipment, the construction of gas piping works, the maintenance and inspection of gas equipment. The Liquefied Petroleum Gas (LPG), Electric and Other Energy segment is engaged in the sale of LPG and the supply of electricity. The Oversea Energy segment is engaged in the leasing of liquefied natural gas (LNG) tankers, the oil and gas-related development and investment, the research and investment of energy supply business. The Environment and Non-energy segment is involved in the development, leasing, management and subdivision of real estates, the leasing and maintenance of automobiles, the manufacture and sale of fine materials and carbon materials, the staff dispatching business, the credit and insurance agency business and the operation of sports facilities. Advisors’ Opinion:

  • [By Damian Illia]

    The company is also aware that its ability to sell non-invase treatment products relies largely on the willingness of third parties to pay for treatment. Therefore, it not only focuses on developing devices to treat sleep apnea and other respiratory problem. It also does on increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated SDB as well as educating caregivers about therapy options. It is estimated that SDB affects 20 percent of the adult population and that 90 percent who have obstructed sleep apnea (OSA) still are and most likely will remain undiagnosed and untreated. The company has therefore created a number of foundations and funds primary care physician programs to educate doctors on SDB. On the other hand, diagnosed COPD patients in America are around 12 million people, but is is estimated that another 12 milion may have the disease and hasn’t been diagnosed yet. Also, ResMed looks forward to c apture those patients who formerly balked at costly, uncomfortable testing in a sleep lad through at-home sleep apnea testing. What this all really means actually, is that ResMed’s potential markets have not really been penetrated and that the growth prospects for the coming years is huge.

Hot Sliver Stocks To Buy Right Now: Synta Pharmaceuticals Corp.(SNTA)

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drug candidates for treating severe medical conditions, including cancer and chronic inflammatory diseases. The company has two drug candidates in clinical trials for treating multiple types of cancer and various drug candidates in the preclinical stage of development. Its oncology product portfolio includes Ganetespib, an Hsp90 inhibitor in various phase 1, 2, and 3 clinical trail programs for various types of cancers, including non-small cell lung cancer, gastrointestinal stromal tumors, hematologic cancers, colorectal cancer, gastric cancer, small cell lung cancer, ocular melanoma, pancreatic cancer, prostate cancer, breast cancer, hepatocellular cancer, and solid tumors; Elesclomol, a mitochondria-targeting agent in phase 2 clinical trails for non-small cell lung cancer and ovarian cancer, as well as in phase 1 clinical trail for acut e myeloid leukemia; STA-9584, a vascular disrupting agent in preclinical development stage for prostate cancer; and various Hsp90 inhibitors in preclinical development stage for cancers. The company?s inflammatory diseases product portfolio includes calcium release activated calcium modulator (CRACM) channel inhibitors in preclinical development stage for autoimmune diseases, respiratory conditions, and transplantation; and IL-12/23 inhibitors in lead optimization stage for autoimmune diseases. It has a license agreement with Hoffman-La Roche for the development and commercialization of compounds from CRACM. Synta Pharmaceuticals Corp. was incorporated in 2000 and is based in Lexington, Massachusetts.

Advisors’ Opinion:

  • [By James E. Brumley]

    Looks out Synta Pharmaceuticals Corp. (NASDAQ:SNTA), and AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), you’re on notice too. Corcept Therapeutics Incorporated (NASDAQ:CORT) is nipping at your heels, and better still, shares of the company looks like they’re about to dole out a sizeable reward to investors who see the writing on the wall.

  • [By Lauren Pollock]

    Synta Pharmaceuticals Corp.(SNTA) said it intends to offer an unspecified number of shares to the public. The biopharmaceutical company has about 69 million shares outstanding. Shares dropped.

Hot Sliver Stocks To Buy Right Now: Tim Participacoes SA (TIMP3)

TIM Participacoes SA (TIM) is a Brazil-based holding company engaged in the telecommunications segment. Through its wholly-owned subsidiaries, TIM Celular SA (TIM Celular) and Intelig Telecomunicacoes Ltda (Intelig), it provides telecommunication services throughout Brazil. TIM Celular and Intelig are active as Public Switched Telephony Network (PSTN) providers in the local and national and international long-distance modalities in all Brazilian states. Additionally, the Company provides multimedia communication services and personal mobile services, mobile data services and a third generation (3G) network, as well as international roaming agreements, multimedia messaging services, blackberry services and sale of related equipment. Advisors’ Opinion:

  • [By Zahra Hankir]

    Brazil’s Ibovespa extended its weekly decline to 3.3 percent. Mobile carrier Tim Participacoes SA (TIMP3) sank after parent Telecom Italia SpA (TIT)’s chief executive officer said its Brazilian assets are strategic, damping speculation the local unit will be sold.

  • [By Jonathan Morgan]

    Telecom Italia SpA (TIT) jumped 6.2 percent to 65.6 euro cents. The phone company that was stripped of its investment-grade rating is seeking at least 9 billion euros for its controlling stake in Brazilian wireless carrier Tim Participacoes SA (TIMP3), according to a person with direct knowledge of the matter.

  • [By Inyoung Hwang]

    Telecom Italia climbed 5.2 percent to 64.2 euro cents, its highest price since May. The telecommunications operator would gain enough funds to improve its domestic business if it sells at least 4 billion euros ($5.4 billion) of shares or its stake in Tim Participacoes SA (TIMP3) in Brazil, according to Goldman Sachs.

Hot Sliver Stocks To Buy Right Now: Twitter (TWTR)

Instantly connect to what’s most important to you. Follow your friends, experts, favorite celebrities, and breaking news. TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking … Advisors’ Opinion:

  • [By Brian Lund]

    jdlasica/flickrMarc Andreessen is bullish on Bitcoin. It’s been a tough couple of weeks for Bitcoin. Hackers have had their way with three Bitcoin sites that hold customer funds, and one, for all intents and purposes, has gone out of business. Poloniex had $50,000 of Bitcoin stolen; Flexcoin reported $600,000 in theft; and Mt. Gox — the first and at one time, the largest exchange — reportedly had $400 million stolen, which caused it to cease business and declare bankruptcy. This turmoil has sent the former golden child of hipster investors plummeting from the nosebleed heights of $1,242 per coin to a low of $419. The virtual currency gods then poured salt into the wound when the Japanese government announced that it intended to regulate Bitcoin — a move that foreshadows similar actions by regulators in North America and the European Union. The dark cloud hanging over the currency got a bit darker — reminding us that though the currency is virtual, the people behind it are real — when it was announced that Autumn Radtke, CEO of bitcoin exchange First Meta, committed suicide at the age of 28. So why hasn’t Bitcoin failed once and for all? The answer doesn’t have to do so much with what is happening now with the currency as it does with who is betting big on its success. Follow the Leaders: Marc Andreessen and Fred Wilson Allow me to introduce you to two people who think Bitcoin is just in its infancy, and whose opinions you should pay attention to: Marc Andreessen and Fred Wilson. You might recognize Andreessen as the co-creator of the first web browser — Mosaic — and co-founder of Netscape Communications, which was purchased by AOL (AOL) (publisher of DailyFinance) in 1999 for $4.2 billion. After that, he went on to form Andreessen Horowitz, one of the premier Silicon Valley venture capital firms, which was an early investor in such obscure start-ups as Facebook (FB), Twitter (TWTR), Groupon (GRPN) and Zynga (ZNGA). You might not recognize Fred Wil

  • [By Jayson Derrick]

    Twitter’s (NYSE: TWTR) first ever 10-k filling shows the company’s ad engagements increased 74 percent quarter over quarter while the company’s average cost per engagement fell 18 percent quarter over quarter and 69 percent year over year. Shares lost 2.37 percent, closing at $53.53.